Value-Driven Drug Development: Unlocking the Value of Your Pipeline [chapter]

Valentina Sartori, Michael Steinmann, Petra Jantzer, Matthias Evers
2014 Collaborative Innovation in Drug Discovery  
Pharmaceutical companies do not need reminding that drug development has become more difficult: even safe and effective drugs struggle to gain regulatory approval and market access. A new paradigm, whereby R&D and commercial teams collaborate at the beginning of Phase 2 to keep a laser-like focus on stakeholder value, can transform performance.
doi:10.1002/9781118778166.ch14 fatcat:3dasnbv2jfgvbmq3v5v735emjq